Shanghai Jmt-bio Inc.

This study is testing a new drug called JMT108 in people with advanced cancers that have not responded to or are not eligible for standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. About 436 adults will take pa…

This study tests a new medicine called JMT202, given as a shot under the skin, for people with very high triglycerides (a type of fat in the blood). The goal is to see if it is safe and how well it works. About 48 Chinese adults with high triglycerides will take part, and some wi…

This study tests whether a new drug combination (KN026 plus HB1801 and chemotherapy) works better than the standard treatment (trastuzumab, pertuzumab, and chemo) to prevent breast cancer from coming back after surgery. It includes 1,800 adults with HER2-positive breast cancer th…

This study tests a new drug, JMT108, in people with advanced melanoma that cannot be removed by surgery or has spread. The goal is to see if the drug is safe and helps shrink tumors. About 188 adults who have tried other treatments or have no standard options will take part.

This early-stage study tests a new drug called JMT106 in 200 adults with advanced solid tumors (such as lung or liver cancer) who have tried other treatments without success. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Parti…

This early-stage study tests a single dose of JMT206 injection in healthy adults aged 18 to 60. The goal is to check if it is safe and how the body processes it. No treatment benefit is expected; it is a first step before testing in patients.